2016-03-03T00:00:00.000-05:00
metabolic disorders,-0.115694
technology,-0.21538
drug profiles,-0.430507
development,-0.0265265
market forecast scenarios,0.317811
likely future growth,0.740587
peptide therapeutics,-0.0987999
unacylated ghrelin analogues,-0.230866
chapter,-0.0845764
various metabolic disorders,-0.40234
overall peptide therapeutics,-0.412688
oral peptide delivery,0.448146
market research solution,0.782687
innovative technology platforms,-0.632242
metabolic indications,-0.289247
Calista Therapeutics,0.211126
common metabolic disorders,-0.780343
research,0.129902
detailed drug profiles,-0.430507
peptide therapeutics market,-0.0281284
peptide based therapies,-0.592627
current market scenario,0.740587
peptides,0.481672
various metabolic diseases,-0.3988
related collaborations,0.254586
product costs,0.254586
future growth outlook,0.740587
drug delivery technology,0.237517
